Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori:Follow-up study of 48cases by Begum, Shahnaz et al.
INTRODUCTION
Malignant lymphomas of the mucosa-associated
lymphoid tissue (MALT) type are an extra-nodal
marginal-zone B-cell lymphoma (1, 2) and the most
common of all gastric lymphomas (3). They may be
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either low or high-grade (2). In low-grade MALT
lymphomas of the stomach, small- to medium-sized
irregular neoplastic B lymphoid cells, so-called
centrocyte-like cells, densely infiltrate the lamina
propria and surround, occasionally invading, the
reactive-type follicles with germinal centers (1, 4).
They also characteristically invade and destroy the
epithelium of the gastric glands to form lympho-
epithelial lesions (1, 4). High-gradeMALT lymphomas,
in which neoplastic B lymphoid cells are larger and
apparently atypical, may either arise de novo or be
transformed from low-grade MALT tumors (2).
It is currently accepted that Helicobacter pylori
(H. pylori) plays a causative role not only in chronic
active gastritis, peptic ulcer diseases and probably
gastric carcinomas (5-7) but also in gastric low-grade
MALT lymphomas (8-10). Clinical studies have
reported high remission rates for low-grade MALT
lymphomas after the cure of H. pylori infection (8-10).
However, little is known about the duration of the
remission because long-term follow-up study is
limited (11). Moreover, data are also limited with
regard to the epithelial changes in the stomach
with MALT lymphomas during a long follow-up
period.
The development of the polymerase chain reaction
(PCR) provides a sensitive tool for the identification
of neoplastic B cell populations by the analysis of
immunoglobulin heavy chain (IgH) gene. However,
the significance of the detection of B-cell monoclonality
in gastric lymphoproliferative lesions by PCR re-
mains controversial, because monoclonality can be
detected not only in neoplastic (8-10) but also in
histologically reactive lesions (10, 12, 13). Its clinico-
pathological significance has yet to be established.
The aims of this histologic and molecular study
on H. pylori-associated gastric lymphoproliferative
diseases including low-grade MALT lymphomas
and chronic gastritis are 1) to assess the duration of
the remission, 2) to clarify the relationship between
histologic change and B-cell clonality, and 3) to
investigate the epithelial changes over a long-term
follow-up period after eradication of H. pylori.
MATERIALS AND METHODS
Patients
Seventy-six patients with H. pylori-infected gastric
lymphoproliferative lesions, either chronic gastritis
or low-grade MALT lymphoma, were studied. All
patients had initially presented with nonspecific
upper gastrointestinal symptoms. All previous clini-
cal records and histopathologic slides were checked
if previous history presented. In MALT lymphoma
cases, the involvement of lymph nodes or other
organs was assessed by physical examination,
routine laboratory tests, chest x-ray, thoracic and
abdominal CT and abdominal ultrasound analysis,
and the lesion was confined to the stomach.
Tissue specimens
On each occasion, the endoscopy was undertaken
by the same endoscopist (Y.U.). The endoscopic
findings alone could not discriminate between
chronic gastritis and low-grade MALT lymphoma
before eradication. Six to ten biopsy specimens
were taken from suspicious areas for histology and
two others for reverse transcriptase-polymerase
chain reaction (RT-PCR) study. The biopsy specimens
were immediately fixed with 10% neutral buffered
formalin and kept at room temperature for one day.
Thin sections were routinely prepared and stained
for hematoxylin and eosin and Giemsa. Biopsy
materials for RT-PCR were stored without fixation
at -80℃ until use.
Eradication and follow-up
All 76 patients received anti-H. pylori therapy
consisting of a combination of lansoprazole (30 mg/
day), metronidazole (500 mg/day) and amoxicillin
(1.5 g/day) for 7 to 14 days. All patients underwent
endoscopy two to four months after completion of
the eradication therapy, and histologic and molecular
analysis was done. Subsequently MALT lymphoma
patients underwent repeated endoscopic, histologic
and molecular analysis at approximately six-month
intervals for up to 45 months after anti-H. pylori
therapy (mean, 20.2 months) (Fig.1), although 2
of them (Cases 26 and 27 in Fig.1) were referred
for surgical treatment. Patients whose initial biopsies
were assessed as showing a reactive lymphoid
infiltrate (chronic gastritis) were followed up only
once or twice for up to 33 months (mean, 8.4 months)
after eradication treatment.
Histologic criteria
Histopathologic grading for differential diagnosis
of gastric lymphoid proliferative lesions was done
using the scoring system of Wotherspoon et al . (8).
Briefly, grades up to 3 were considered reactive
(chronic gastritis) and grades 4 and 5 neoplastic
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(low-grade MALT lymphoma). The criteria for the
diagnosis of low-grade gastric MALT lymphomas
were the detection of lymphoepithelial destruction,
and the presence of dense diffuse infiltrates of
centrocyte-like cells in lamina propria and germinal
centers. Presence or absence of lymphoepithelial
lesions, lymphoid aggregates and lymphoid follicles
was evaluated for differential diagnosis.
Measurement of the degree of “empty lamina propria”
Histologic change in the degree of so-called“empty
lamina propria”was morphometrically followed up
in 10 selected MALT lymphoma cases for up to 37
months. Nine chronic gastritis cases were also
studied as a control for up to 22 months. This
change was characterized by loose connective
tissue with scattered plasma cells, an absence of
Table 1. Sequences of primers for PCR
(For immunoglobulin heavy chain)
(Upper-stream)
VH1LS ; 5’-CAT GGA CTG GAC CTG GAG G-3’
VH2+4LS ; 5’-CAT GAA ACA CCT GTG GTT CTT-3’
VH3LS ; 5’-GGG CTG AGC CTG GGT TTT CCT T-3’
VH5LS ; 5’-GGG GTC AAC CGC CAT CCT-3’
VH6LS ; 5’-TCT GTC TCC TTC CTC ATC TTC-3’
(Down-stream)
Cµ ; 5’-GGT TGG GGC GGA TGC ACT-3’
(For nested)
VHFR2 ; 5’-GC(C/T) (C/T)CC GG(A/G) AA(A/G)
(A/G)GT CTG GAG TGG-3’
(For GAPDH as an internal control)
(Upper-stream)
GAPDH-UP ; 5’-GAAATCCCATCACCATCTTCCAGG-3’
(Down-stream)
GAPDH-DN ; 5’-CATGTGGGCCATGAGGTCCACCAC-3’
Case
Age/SexNo
Group 1 : Histologically and molecularly regressed cases
Case
Age/SexNo
Group 3 : Persistent monoclonal cases after
histologic regression
 -H. pylori eradication therapy was given ; ●-MALT lymphoma, histologically ; ○-Histological regression occurred ; ◎-Chronic gastritis,
histologically ; ■-Monoclonal by PCR ; □-Polyclonal by PCR ; □-PCR was not performed ; ▲-Surgical treatment was given. For example, ●
means histologically MALT lymphoma and monoclonal by PCR
Fig.1. Histopathologic and RT-PCR results during follow-up for 48 low-grade gastric MALT lymphoma patients.
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organized collections of lymphoid cells, and a loss
of gastric glands (10). Measurement of the“empty
lamina propria”was done as follows : the 3 most
prominent areas were selected in each case and
photographed at a magnification of 160 times under
a microscope. The field of one photograph (110.88
cm2) was divided into 176 squares and the number
of squares containing“empty lamina propria”was
counted. The mean value (%,“empty lamina propria”
area/total area) was calculated by analyzing 3
photographs.
Immunohistochemistry
An immunohistochemical study was done on 20
MALT lymphoma and 5 chronic gastritis patients.
According to previously described methods (14),
the procedure was performed with L26 (CD20, 1 :
100 ; DAKO, Carpinteria, USA) for B lymphocytes
and CD3 (1 : 100 ; DAKO) for T lymphocytes.
Reverse transcriptase-polymerase chain reaction
(RT-PCR)
RT-PCR for detection of rearranged IgH genes
in proliferating lymphoid cells was performed in 45
MALT lymphoma and 20 chronic gastritis cases
before eradication. Materials in the remaining 3
MALT lymphoma cases were not available. After
eradication, biopsy materials for RT-PCR were avail-
able in all 48 MALT lymphoma cases.
RNA Extraction : Total RNA was extracted from
the samples by the modified acid-guanidinium-
thiocyanate-phenol-chloroform (AGPC) method (15)
using ISOGEN RNA extracting mixture (Nippon Gene,
Toyama, Japan) according to the manufacturer’s
recommendations. When intact 28S and 18S ribo-
somal RNAs were visualized on agarose gel, total
RNA from the samples was subjected to RT- PCR.
RT-PCR : In order to identify monoclonal B cell
proliferation in the gastric lesions, we amplified the
entire VH region of IgH cDNA by RT-PCR. For
reverse-transcription, 5 µg of total RNA was incubated
with M-MLV (Life Technologies, Inc. Gaithersburg,
USA) and a dNTP mixture (500 µM each ; Life
Technologies, Inc.) at 42℃ for 60 min using a
random primer (5 µM ; Life Technologies, Inc.) in
20 µl of a reaction mixture. Subsequently, 1 µl of the
products was subjected to PCR amplification (16).
We used a mixture of five leader sequence primers
(VH1LS, VH2+4LS, VH3LS, VH5LS and VH6LS ;
Table1) corresponding to 6 VH regions in IgH genes
as an upper-stream primer, and a Cµ sequence
(Table 1) in the CH 1 region as a down-stream
primer. We used a pair of primers for GAPDH
gene (GAPDH-UP and GAPDH-DN ; Table 1) as
an internal control for an adequate PCR reaction.
PCR was performed as follows ; the final concentra-
tion of dNTPs and primers in the reaction mixture is
200 µM and 1 µM, respectively. Taq DNA polymerase
(Takara, Shiga, Japan) was added to the mixture at
a final concentration of 0.05 U/µl and the reaction
was carried out in Takara Thermal Cycler MP
(Takara) under the following conditions ; 94℃ for
3 min and then 94℃ for 1 min, 55℃ for 1.5 min,
and 72℃ for 2.5 min for the desired number of
cycles and an extension of 72℃ for 4 min. In some
cases, we performed semi-nested PCR to confirm the
reliability and the reproducibility of our experiment
using the same upper-stream primer mixture for
first PCR and a new down-stream primer (VHFR2 ;
Table 1) at the FR2 region in IgH gene. Then,
PCR amplification was done under the conditions
described above. The PCR products were electro-
phoresed in 1.7% agarose gel or 5% polyacrylamide
gel and visualized under ultraviolet light after
ethidium bromide staining. The size of PCR products
was evaluated by comparison with either Pvu2
digested pBK-CMV or Hap2 digested pUC19.
We used one B cell lymphoma sample as a positive
control and mononuclear cells in peripheral blood
prepared from a healthy volunteer as a negative
control. To eliminate the possibility of the contami-
nation of positive samples in the reagents, one
sample without template was also added in each
experiment. For each case, the reactions were done
at least in duplicate, and only the cases with a
dominant band of identically sized fragments were
considered to contain a monoclonal B cell population.
Statistical analysis
Statistical differences were evaluated using Stu-
dent’s t-test and Paired t-test, as applicable. A value
of P<0.05 was considered statistically significant.
RESULTS
Histopathology
As defined in Materials and Methods, histologic
evaluation of 76 patients distinguished a reactive
lymphoid infiltrate (score 2-3) in 28 cases (16 males
and 12 females) and features suggestive or diagnostic
low-grade MALT lymphoma (score 4-5) in 48 (25
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males and 23 females). Patients with chronic gastritis
presented at a mean age of 45.2 years (range 32-
55) and low-grade MALT lymphoma at 49.4 years
(range 31-71) (Table 2). H. pylori organisms were
identified in the initial biopsy specimens in all
cases by examination of the Giemsa stained sections.
Clinical and histologic comparative results of 76
patients are shown in Tables 2, 3 and 4. In cases of
chronic gastritis, the mononuclear infiltrate consisted
of small lymphocytes with round nuclei and plasma
cells, but few or no centrocyte-like cells (Fig.2). As
shown in Table 3, the infiltrate was either mild
(9 cases), moderate (18 cases) or severe (1 case).
Lymphocytes infiltrating epithelium but not lympho-
epithelial lesion were present in 9 cases (32%),
lymphoid aggregates in 23 (82%) and follicles
with germinal centers in 8 (28%). Eradication of H.
pylori was achieved in all chronic gastritis cases.
These patients were followed up for a mean of 8.4
months (range 2-33) after H. pylori treatment. A
remarkable decrease in the lymphoid infiltrate was
observed at the first post-therapy evaluation (within
2 months) ; lymphoid aggregates were seen in 9
cases (32%) and lymphoid follicle in one case (3%)
(Table 3).
In all 48 MALT lymphoma cases, centrocyte-like
cells, lymphoepithelial lesions and lymphoid follicle
Table 2. Clinical profile in the cases of chronic gastritis and MALT lymphoma
Number
of
cases
Sex
Male Female
Age (year)
mean (range)
Follow-up period (month)
mean (range)
Follow-up period after
eradication (month)
mean (range)
Chronic
gastritis
MALT
lymphoma
28
48
16 12
25 23
45.2 (32-55)
49.4 (31-71)
10.6 (4-36)
28.9 (4-113)
8.4 (2-33)
20.2 (3-45)
Table 3. Comparison of the histopathologic and molecular findings between patients with chronic gastritis and MALT lymphoma
before and after H. pylori eradication
Type of
lesion
Stage
Chronic inflammation
Mild/Moderate/Severe
Lymphoid
aggregates
Lymphoid
follicles
LEL Cystic
change
B cell★
monoclonality
Chronic
gastritis
(n=28)
Before ER
After ER
9
28
18
0
1
0
23
*
9
8
**
1
0
0
0
4
6
NS
3
MALT
lymphoma
(n=48)
Before ER
After ER
HR (n=43)
HNR (n=5)
0
36
2
7
5
46
0
48
*
23
5
48
*
8
5
48
0
5
0
28
43
*
21
5
LEL : Lymphoepithelial lesion, ER : Eradication, HR : Histologically regressed cases, HNR : Histologically non- regressed cases,
★ : Twenty chronic gastritis and 45 MALT lymphoma cases were analyzed for B cell monoclonality before eradication,
NS : Not significant
*p<0.001, **p<0.05, by Paired t-test.
Fig.2. Chronic gastritis. Small lymphocytes with round nuclei,
plasma cells and rare centrocyte-like cells infiltrate the lamina
propria. (Hematoxylin-eosin stain ; original magnification×150)
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were present (Fig.3). Eradication of H. pylori was
achieved in all cases (2 after a second treatment
course). Patients were followed up for a mean of 20.2
months (range 3-45) after H. pylori treatment and
17.8 months (range 0-43) after histologic remission.
As shown in Fig.1, histologic regression was seen
in 43 of 48 patients (89%) and was evident in the
first post-treatment biopsy performed 2 to 4 months
after eradication in 32 cases (72%) (Fig. 4a). Among
the remaining 11 cases, histologic regression was
observed 4 to 8 months later in 10 cases and 22
months later in one case (Case 1). Small lymphocyte
clusters without centrocyte-like cells were seen in
23 cases (48%), and lymphoid follicles in 8 cases
(23%) (Table 3). In one patient (Case 48), relapse
of MALT lymphoma was associated with reinfec-
tion. This reinfection was retreated and the patient
was then in remission stage.
Low-grade MALT lymphoma was also diagnosed
by retrospective re-evaluation of histology which
was done for biopsy specimens taken from 5 patients
2, 5, 6, 8 and 8 years before the present study,
respectively (Cases 6, 16, 19, 25 and 27 in Fig.1).
Three of these 5 patients’histologic regression
occurred after eradication (Fig.1).
Among 48 patients with low-grade MALT lymphoma,
5 patients showed no histologic regression after
H. pylori treatment. Two were referred for surgical
treatment and histologic analysis revealed a com-
ponent of high-grade lymphoma in the resected
stomach (Cases 26 and 27 in Fig.1). The remaining
3 patients were followed up for 6, 10 and 13 months
and showed no histologic change (Cases 23-25 in
Fig.1).
We followed up the change in the degree of
“empty lamina propria”(Table 4). In chronic gastritis
cases, there was no significant difference in the
degree of empty lamina propria between initial ob-
servation (mean, 57%) and final observation (mean,
54%) (P=0.7338). On the other hand, in MALT
Fig.3. Low-grade gastric MALT lymphoma. Mucosal infiltration
by centrocyte-like cells that form prominent lymphoepithelial
lesions (score 5) (Hematoxylin-eosin stain ; original magnifica-
tion×150)
Fig.4a. Low-grade gastric MALT lymphoma. Five months after
eradication, there are occasional small lymphoid aggregates
with loss of gastric glands within an empty-appearing lamina
propria. (Hematoxylin-eosin stain ; original magnification×150)
Fig.4b. Forty-five months after eradication, emptiness of the
lamina propria has markedly decreased and the glandular area
increased. (Hematoxylin-eosin stain ; original magnification×150)
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lymphoma cases, there was a significant difference
in the degree of empty lamina propria between
initial and final observation (P=0.0002) (Fig. 4b). It
decreased gradually ; in the first observation (4
months of post-eradication) the mean value was
80%, in 12 months 67%, in 24 months 62% and in
28.2 months 59% (Table 4).
After eradication, dilatation of the fundic gland
was seen in 4 chronic gastritis cases (14%) and 28
MALT lymphoma cases (58%). Dilatated glands of
various size were surrounded by normal fundic
gland and lined by parietal cells, chief cells and
mucous secreting cells (Fig.5). Lingular projection
of parietal cells was also seen in 4 MALT lymphoma
cases.
Immunohistochemistry
Immunohistochemical analysis confirmed the
B-cell predominance within the lymphoid infiltrates ;
the majority were L26 positive-B cells but CD3
positive-T cells were also present. Lymphoid ag-
gregates and germinal centers which were located
deep in the mucosa were of B lineage. Lymphocytes
in lymphoepithelial lesions were phenotyped as B
lineage cells but a few T cells were also noted.
Reverse transcriptase-polymerase chain reaction
(RT-PCR)
Among 20 chronic gastritis cases in which RT-PCR
was performed, in 6 there was evidence of a clonal
population before H. pylori treatment. Follow-up
biopsies after eradication (mean 15.1 months ; range
8-33) showed continued absence of histologic fea-
tures of lymphoma but RT-PCR showed persistence
of a clonal band in 3 of these 6 cases.
As shown in Fig.1, RT-PCR was performed in 45
MALT lymphoma cases before eradication and a
detected monoclonal band in 43 cases and polyclonal
band in 2 cases (Cases 13 and 21). After eradication,
RT-PCR was performed in 48 MALT lymphoma
cases. In the first post-treatment analysis (2 to 4
months after eradication), a polyclonal band was
detected in 12 cases and monoclonal band in 36
cases. During the follow-up period, in 10 of these
36 cases there was a change to a polyclonal band
while in 26 cases (21 histologically regressed cases
and 5 non-regressed cases), the monoclonal band
persisted.
In 4 cases (Cases 20 and 32-34 in Fig.1), in spite of
histologic features of a reactive lymphoid infiltrate
(score 2), RT-PCR detected a monoclonal population
in the first biopsy. Rebiopsy, done 3 to 19 months
later but before eradication, revealed histologic
evidence of MALT lymphoma.
DISCUSSION
It is now commonly accepted that gastric B-cell
MALT lymphoma is, in most cases, a sequela of H.
pylori-induced, T-cell mediated chronic gastritis (17).
The finding of regression of MALT lymphoma
brought about by eradication of H. pylori infection
is an important step in establishing a role for H.
pylori in the events leading to MALT lymphoma (8-
10). Further evidence of a role for H. pylori came
from case reports in which reinfection with H.
pylori resulted in a relapse of MALT lymphoma
(18, 19).
Epithelial changes of regressed patients with
Table 4. Degree of empty lamina propria (%) during follow-up
Month of follow-up (mean)
4 m 12 m 24 m 28.2 m
Chronic
gastritis
(n=9)
57 54
NS
MALT
lymphoma
(n=10)
80 67 62 59
P=0.0003
P=0.0005
P=0.0002
NS : Not significant
Fig.5. Low-grade gastric MALT lymphoma. After eradication,
multiple glandular cysts are seen in the corpus mucosa.
(Hematoxylin-eosin stain ; original magnification×87)
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MALT lymphoma during long-term follow-up have
not been evaluated in other trials. In the present
study, we focused on particularly empty lamina
propria that was more pronounced in the case of
MALT lymphoma than chronic gastritis. The dem-
onstration of a more pronounced empty lamina
propria in MALT lymphoma cases indicates possible
dense lymphoid infiltration. During the follow-up
period (mean 28.2 months ; range 13-37), the area
of empty lamina propria decreased and the glandular
area increased which was statistically significant.
These results suggest that regenerative change of
the damaged glands caused by lymphoepithelial
lesions may occur in histologically regressed cases.
Reversal of glandular atrophy in patients with chronic
gastritis after eradication has been recently reported
but the results in these reports have been conflict-
ing. While in a few studies reversal of atrophy was
found in all or almost all atrophic gastritis patients
examined (20-22), only a few or no patients showed
reversal of atrophy in other studies (23, 24). This
discrepancy may be due to different locations and
grades of atrophic gastritis. Reappearance of parietal
and chief cells following corticosteroid and anti-ulcer
drug sulglycotide treatment in patients with atrophic
gastritis has been reported (25-27). These results
further support our speculation that regeneration
takes place after H. pylori eradication. In the chronic
gastritis cases, the gastric gland also recovered but
the extent of the recovery was not significant. This
may be due to the less dense lymphoid infiltrate in
our study. The relatively short-term follow-up (mean
12.2 months ; range 12-33) may also explain the
discrepancy (20-22).
The presence of dilated glands and intramucosal
cysts lined by parietal, mucus and chief cells is the
histologic hallmark of fundic gland polyp (28). In
our series, there were lesions where histology fulfilled
the criteria for the diagnosis of fundic gland polyps
but endoscopic features were absent. The fact that
cystic change of the fundic gland was seen in 28
MALT lymphoma cases (58%) and in 4 chronic
gastritis cases (14%) after H. pylori eradication sug-
gests a relationship between eradication therapy
and cystic change of the fundic gland. Recent reports
have found an association between fundic gland
polyp and chronic omeprazole use (29, 30). Ang et
al . have recently speculated that cysts, parietal cell
hypertrophy and lingular projections of parietal cells
are likely to be forerunners to the fundic gland
polyps in some patients receiving long-term omeprazole
therapy (31). However, in our studies we found
lingular projection of parietal cells only in 4 cases.
The reason for this discrepancy may be that the
treatment period (10 -14 days) in our study was
shorter than those in the previous study groups.
For the differential diagnosis of reactive and
neoplastic lymphoid proliferation in the gastric
mucosa, most reports have focused on the detection
of monoclonality (8-10). However, the significance
of the detection of B-cell monoclonality by PCR
remains controversial, because monoclonality is
detected not only in neoplastic (8 -10) but also in
histologically reactive lesions (10, 12, 13). In our
series, in fact, 10 cases showed histologic features
of a reactive lymphoid infiltrate with a PCR de-
tectable monoclonal population. In the absence of
histologic signs of low-grade gastric MALT lymphoma,
the presence of monoclonal B cells may indicate a
special or peculiar form of gastritis with a monoclonal
evolution of B cells or suspicious borderline lesion
(32). Whether these B cells are prone to evolve
into early gastric MALT lymphoma can only be
speculated presently. During the follow-up period,
histologic features of lymphoma did not develop in
the 6 patients eradicated of chronic gastritis with
monoclonality in our series and in others (10, 13). In
low-grade MALT lymphoma, the cure of H. pylori
infection induces complete histologic remission in
the majority of cases and the relapse rate is also
low. So it is natural that after eradication of H.
pylori, histologic features of monoclonal chronic
gastritis may be sustained. In contrast, among those
10 monoclonal chronic gastritis cases, histologic
evidence of lymphoma was found in 4 cases during
follow-up. Before eradication of H. pylori, we per-
formed a second histologic examination in these 4
cases. In addition to our series, MALT lymphoma
developed in 14 monoclonal chronic gastritis cases
after more than 1 year of follow-up without eradica-
tion of H. pylori (33). A PCR detectable population
in the absence of histologic features of lymphoma
might therefore represent a peculiar tumor pro-
gression stage when the clonal population is large
enough to be detected by PCR but not by histology.
It seems that monoclonality precedes histologic
neoplastic transformation and that a diagnosis of
B-cell malignancy should not be based solely on
the detection of a monoclonal rearrangement of
the IgH gene by PCR.
In 21 cases with low-grade MALT lymphoma,
there was persistent molecular evidence of a clonal
population after histologic regression. It is not clear
whether these patients still suffer from the disease
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or monoclonality only indicates the presence of
benign memory B-cell precursors of the malignant
clone (32). The patients with monoclonal PCR
bands may be more likely to have a relapse of
their disease. There was only one case of relapse
in our series, and the patient was monoclonal before
the relapse was detected. The rapid recurrence of
MALT lymphoma in our case could be explained
by regression of the pathologic features of MALT
lymphoma caused by H. pylori eradication and
persistence of the neoplastic cells in a latent form.
Subsequently, re-exposure to the H. pylori might
result in reactivation of the neoplastic cells and rapid
relapse of the MALT lymphoma (18). It is difficult
to draw any conclusion at present. Follow-up studies
will answer the question of whether patients with
monoclonal B cells are at high risk of relapse of
the disease.
Low-grade MALT lymphoma was diagnosed by
retrospective re-evaluation of histology in 5 cases
and a spontaneous cure was not seen in any of
these cases within this period. We predict that a
natural cure is possible. A decrease in H. pylori in
the stomach has been considered to be caused by
mucosal atrophy with intestinal metaplasia (34) and
mucosal destruction (33). We speculate that intes-
tinal metaplasia creates a hostile environment for
H. pylori which can lead to a natural cure although
it may take a long time.
Most of the studies published to date have not
described the duration of the remission of MALT
lymphomas after the cure of H. pylori infection.
Complete remissions were obtained in 43 of 48
patients (89%) in our series and continued through-
out the follow-up period (mean 17.8 months ; range
0-43), suggesting that most patients who achieve a
complete remission do not relapse within a short
period of time. Recently, one follow-up study by
Neubauer et al. revealed 40 patients in complete
remission for a median of 14 months similar to our
analysis (11). Only one relapse of MALT lymphoma
was observed in our series but it was associated
with reinfection of H. pylori. Case reports on relapse
of the low-grade MALT lymphoma are very rare
and in most of the cases relapse of MALT lymphoma
was associated with reinfection of H. pylori (18, 19).
In 5 patients, no histologic change of low-grade
MALT lymphoma was seen after cure of H. pylori
infection. Of these 5 patients, 2 underwent surgery
and a high-grade lymphoma component was detected
which was not detected in previous gastric biopsy
specimens. Gastric MALT lymphoma may be the
result of a multistep process in which a T-cell-driven
B-cell growth first leads to monoclonal B-cell prolif-
eration (17), and then to the typical lymphoepithelial
lesion (8), then a low-grade B-cell clone evolves
that may not depend on T-cell help (35) and finally
a high-grade B-cell clone can be found which may
be dependent upon additional genetic changes such
as p53 alteration (36) and bcl-6 protein (37). In a
recent review by Isaacson (35), it was pointed out
that the regressed low-grade MALT lymphomas
following the eradication of H. pylori were all in an
early phase. Patients not responding to cure of H.
pylori infection may be in a progressive stage of
the disease.
In conclusion, our results suggest that 1) regen-
erative change of the gastric mucosa occurs in the
histologically regressed MALT lymphoma, 2) genetic
monoclonality precedes histologic neoplastic trans-
formation, and 3) long-lasting remissions can be
acquired after the cure of H. pylori infection in
patients with early stage low-grade gastric MALT
lymphoma. Due to the indolent nature of low-grade
MALT lymphoma, the possibility of reinfection and
subsequent relapse of MALT lymphoma requires
regular follow-up.
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